Genetic News and Research

RSS

Risk factors of malignant arrhythmias found in patients treated with therapeutic hyperthermia after cardiac arrest

Researchers showed that 20-50% of patients developed an irregular heartbeat that required defibrillation during the active cooling phase of therapeutic hypothermia following an out-of-hospital cardiac arrest.

5 Nov 2019

Tumor cell plasticity counts during cancer metastasis

Cancer metastasis, which is the propagation of tumor cells into distant organs, is the leading cause of cancer patient mortality.

5 Nov 2019

Mosaicism of IVF embryos does not pose any health risks to future babies

Compared to the mother's body, the egg fertilized in a test tube has rather different conditions for growing.

5 Nov 2019

Researchers propose genetic testing and continued management of identical twin kidney transplants

Using U.S. transplant registry data, clinical researchers at the University of Pittsburgh School of Medicine found that kidney transplants between identical twins have high success rates, but also high rates of immunosuppressant use.

5 Nov 2019

Study supports physical activity as a preventive measure for depression

A new study has found that physical activity may have a preventative effect against depression. Physical activity has long been linked with better mental health due to its ability to reduce the stress hormone cortisol and increase the feel-good hormone serotonin. However, there has been limited empirical evidence to support physical activity as a preventive measure for depression, making these findings very important.

5 Nov 2019

Bariatric surgery may cut genetic risk for developing breast cancer

Women with a genetic predisposition for breast cancer were 2.5 times more likely to develop a malignancy than women with the same genetic risk who underwent bariatric or weight-loss surgery, according to a new study presented today by Cleveland Clinic Florida researchers at the 36th American Society for Metabolic and Bariatric Surgery Annual Meeting at ObesityWeek 2019.

5 Nov 2019

Biomarker reveals if benign-appearing meningiomas are dangerous

A modified protein in benign-appearing meningiomas can reveal which are truly benign and which are more dangerous and require more aggressive treatment, researchers have discovered.

5 Nov 2019

Newly identified gene variant may offer potential treatment for Alzheimer's disease

Defying the odds, an individual at high risk for early-onset Alzheimer's disease remained dementia-free for many years beyond what was anticipated.

4 Nov 2019

Researchers develop new type of transposase protein with improved biochemical properties

The team, comprising researchers from the European Molecular Biology Laboratory, the Universitätsklinikum Würzburg and the Paul-Ehrlich-Institut, managed to design a new variant of the Sleeping Beauty transposase with dramatically improved biochemical properties.

4 Nov 2019

UK aims to lead with cutting-edge radiation therapy

The UK is all set to launch its run into the future as the undisputed leader in the field of personalized and effective radiation therapy. The proposal is undergirded by a whopping £56 million, which will be used to set up and fund advanced radiation therapy research by a new collaborative setup, Cancer Research UK RadNet, over five years. This is the largest sum ever invested by this organization into radiotherapy research.

4 Nov 2019

Facts about lung cancer and ways to reduce your risk

Lung cancer is the second most common cancer in both men and women in the United States. According to the American Cancer Society, about 13% of all new cancers are lung cancers. There will be an estimated 228,000 new cases of lung cancer this year, with more than 142,000 deaths. Moreover, the 5-year survival rate is less than 20%.

4 Nov 2019

Researchers discover way to find genetic tumor information of retinoblastoma

Retinoblastoma is a cancer that forms in the light-detecting cells in the back of the eye. It often appears in children under two years of age and can lead to blindness or eye removal. Most cancers are biopsied and studied so that medical research can design targeted treatments. Unfortunately, this is not possible with retinoblastoma.

4 Nov 2019

New guide for genomic diagnosis of myelodysplastic syndromes and chronic myelomonocytic leukemia published

In Spain, a workgroup of more than 400 researchers, the Spanish Group of Myelodysplastic Syndromes, meets twice a year to present projects and undertake collaborations that improve their work in the fight against Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia, two types of blood cancers.

4 Nov 2019

Genetic mutation of APOE gene may provide protection against Alzheimer's disease

A team of researchers has identified that a genetic mutation of the APOE gene, the major susceptibility gene for late-onset Alzheimer's disease, may provide protection against the devastating neurological illness.

4 Nov 2019

Researchers decipher gene function that protects against type 2 diabetes

Type 2 diabetes affects almost 400 million people across the world. It is caused by a combination of lifestyle as well as genetic factors which together result in high blood sugar levels.

4 Nov 2019

Self-sampling could increase detection of cervical pre-cancer

A non-invasive test to detect cervical pre-cancer could increase participation rates in cervical cancer screening programs.

4 Nov 2019

A type of gut bacteria may increase risk of bowel cancer

People with a certain type of bacteria in their guts may be more likely to develop bowel cancer.

4 Nov 2019

Some deadly skin cancers may originate in hair follicles

Some deadly skin cancers may originate in the pigment-making stem cells in hair follicles rather than in skin.

4 Nov 2019

Some skin cancers may originate in hair follicles

Some of the most deadly skin cancers may start in stem cells that lend color to hair, and originate in hair follicles rather than in skin layers, a new study finds.

4 Nov 2019

Innovative research network marks a new era of radiotherapy research in the UK

The UK will be transformed into a global hub for radiotherapy research, pioneering the use of the latest techniques such as FLASH radiotherapy and artificial intelligence, with a new £56 million research network announced by Cancer Research UK today (Monday).

4 Nov 2019